Ultraschall-gezielte Botulinumtoxin-Therapie in der Neurologie: etablierte Indikationen und Techniken

Uwe Walter

doi:10.1055/a-1026-0969

Klinische Neurophysiologie, Table of Contents

Klinische Neurophysiologie 2019; 50(04): 227-234
DOI: 10.1055/a-1026-0969

Sonografie von Nerven und Muskeln

Ultraschall-gezielte Botulinumtoxin-Therapie in der Neurologie: etablierte Indikationen und Techniken

Ultrasound-guided botulinum toxin treatment in neurology: established indications and techniques

Authors

Uwe Walter

¹Klinik und Poliklinik für Neurologie, Universitätsmedizin Rostock, Rostock

²Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, Standort Rostock

Abstract

Zusammenfassung

Botulinumtoxin (BT) wird in der Neurologie eingesetzt zur Behandlung von Erkrankungen mit Muskelhyperaktivität, wie Dystonie, Spastik und Zerebralparese, muskulär bedingten Nervenengpass-Syndromen, sowie von Erkrankungen mit Hyperaktivität exokriner Drüsen.

Mittels Ultraschall (US) kann die gesamte Prozedur der BT-Injektion in oberflächennahe Muskeln und Drüsen in Echtzeit visualisiert und geführt werden. Die Ergebnisse verschiedener Studien sprechen dafür, dass die US-gezielte im Vergleich zur konventionellen Injektionstechnik den Effekt der BT-Therapie verbessert und Nebenwirkungen reduziert. Die US-gezielte Injektionstechnik ist heute etabliert zur BT-Injektion in die Glandula parotis und die Glandula submandibularis bei neurologischen Erkrankungen mit Hypersalivation. Des Weiteren ist die US-gezielte BT-Injektion zu empfehlen bei komplizierten Formen der zervikalen Dystonie sowie bei dystonem Kopftremor, insbesondere zur Injektion der Mm. scaleni, des M. obliquus capitis inferior und des M. longissimus capitis. Die US-gezielte BT-Injektion ist Standard bei der Behandlung spezifischer Unterarmmuskeln (z.B. einzelner Fingerflexoren), wenn deren Funktionalität von Bedeutung ist, insbesondere bei tätigkeitsassoziierten Dystonien und bei milder Spastik. Die US-gezielte Injektionstechnik ist sinnvoll bei Therapie bestimmter Beinmuskeln. In dieser Übersicht werden die Technik und die häufigen neurologischen Indikationen der US-geführten BT-Injektion vorgestellt.

Abstract

Botulinum toxin (BT) therapy is used in neurology to treat muscle hyperactivity disorders including dystonia, spasticity and cerebral palsy, nerve entrapment syndromes caused by muscles, as well as exocrine gland hyperactivity disorders. Ultrasonography (US) can visualise and guide the entire procedure of BT application into muscles and glands. The results of several studies suggest that US-guidance can improve efficacy and reduce adverse effects of BT therapy when compared to conventional placement. US is meanwhile established for guiding the BT injection into the parotid and submandibular glands in neurological disorders with sialorrhea. Moreover, US-guidance of BT-injection is recommendable for use in patients with complicated forms of cervical dystonia and dystonic head tremor, especially for exactly targeting the scaleni, obliquus capitis inferior, and longissimus capitis muscles. US-guidance can be regarded as being state-of-the-art in the treatment of single forearm muscles (e.g., single finger flexors) if their functionality matters, especially in task-related dystonia, and mild spasticity. US is recommended for guidance of BT injection in selected leg muscles. Here the technique and indications of US-guidance for BT injection in neurological disorders are reviewed.

Schlüsselwörter

Myosonologie - Botulinumtoxin - Dystonie - Spastik - Hypersalivation - Ultraschall-gezielte Injektion

Key words

myosonology - botulinum toxin - dystonia - spasticity - hypersalivation - ultrasound-guided injection

Full Text

References

Literatur
1 Dressler D. Clinical applications of botulinum toxin. Curr Opin Microbiol 2012; 15: 325-336
2 Jankovic D, Peng P, van Zundert A. Brief review: Piriformis syndrome: etiology, diagnosis, and management. Can. J Anesth 2013; 60: 1003-1012
3 Torriani M, Gupta R, Donahue DM. Botulinum toxin injection in neurogenic thoracic outlet syndrome: results and experience using a ultrasound-guided approach. Skeletal Radiol 2010; 39: 973-980
4 Su PH, Wang TG, Wang YC. Ultrasound-guided injection of botulinum toxin in a patient with omohyoid muscle syndrome: a case report. J Clin Ultrasound 2013; 41: 373-376
5 Aurora SK, Winner P, Freeman MC. et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache 2011; 51: 1358-1373
6 Naumann M, Dressler D, Hallett M. et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders. Toxicon 2013; 67: 141-152
7 Jost WH, Friedman A, Michel O. et al. SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea. Neurology 2019; 92: e1982-e1991
8 Jost WH, Bäumer T, Laskawi R. et al. Therapie der Sialorrhoe mit Botulinumtoxin. Fortschr Neurol Psychiatr 2019; 87: 554-563
9 Barbano RL. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is useful. Muscle Nerve 2001; 24: 1567-1568
10 Childers MK, Wilson DJ, Gnatz SM. et al. Botulinum toxin type A use in piriformis muscle syndrome: a pilot study. Am J Phys Med Rehabil 2002; 81: 751-759
11 Jordan SE, Ahn SS, Gelabert HA. Combining ultrasonography and electromyography for botulinum chemodenervation treatment of thoracic outlet syndrome: comparison with fluoroscopy and electromyography guidance. Pain Physician 2007; 10: 541-546
12 Mashayekh A, Christo PJ, Yousem DM. et al. CT-guided injection of the anterior and middle scalene muscles: technique and complications. AJNR Am J Neuroradiol 2011; 32: 495-500
13 Walter U, Dressler D. Botulinumtoxin-Therapie in der Neurologie: Indikationen, Technik und Ultraschallsteuerung. Klin Neurophysiol 2015; 46: 56-64
14 Schmidt WA, Backhaus M, Sattler H. et al. Imaging techniques in rheumatology: sonography in rheumatoid arthritis. Z Rheumatol 2003; 62: 23-33
15 Boon AJ, Oney-Marlow TM, Murthy NS. et al. Accuracy of electromyography needle placement in cadavers: non-guided vs. ultrasound guided. Muscle Nerve 2011; 44: 45-49
16 Peetrons P. Ultrasound of muscles. Eur Radiol 2002; 12: 35-43
17 Pillen S, Tak RO, Zwarts MJ. et al. Skeletal muscle ultrasound: correlation between fibrous tissue and echo intensity. Ultrasound Med Biol 2009; 35: 443-446
18 Zaidman CM, van Alfen N. Ultrasound in the Assessment of Myopathic Disorders. J Clin Neurophysiol 2016; 33: 103-111
19 Walter U. How small can small nerves be for diagnostic ultrasonography?. Ultraschall Med 2019; 40: 400-402
20 Kopf H, Mostbeck GH, Loizides A. et al. Ultrasound-guided interventions at peripheral nerves: diagnostic and therapeutic indications. Ultraschall Med 2011; 32: 440-456
21 Hobson-Webb LD, Boon AJ. Reporting the results of diagnostic neuromuscular ultrasound: an educational report. Muscle Nerve 2013; 47: 608-610
22 Walter U, Dressler D. Ultrasound-guided botulinum toxin injections in neurology: technique, indications and future perspectives. Expert Rev Neurother 2014; 14: 923-936
23 Schramm A, Bäumer T, Fietzek U. et al. Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement. J Neural Transm (Vienna) 2015; 122: 1457-1463
24 Katz P, Hartl DM, Guerre A. Clinical ultrasound of the salivary glands. Otolaryngol Clin North Am 2009; 42: 973-1000
25 Dogu O, Apaydin D, Sevim S. et al. Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin Neurol Neurosurg 2004; 106: 93-96
26 Petracca M, Guidubaldi A, Ricciardi L. et al. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview. Toxicon 2015; 107 (Pt A) 129-140
27 Porta M, Gamba M, Bertacchi G. et al. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001; 70: 538-540
28 Breheret R, Bizon A, Jeufroy C. et al. Ultrasound-guided botulinum toxin injections for treatment of drooling. Eur Ann Otorhinolaryngol Head Neck Dis 2011; 128: 224-229
29 Jeung IS, Lee S, Kim HS. et al. Effect of botulinum toxin a injection into the salivary glands for sialorrhea in children with neurologic disorders. Ann Rehabil Med 2012; 36: 340-346
30 Reichel G. Cervical dystonia: A new phenomenological classification for botulinum toxin therapy. Basal Ganglia 2011; 1: 5-12
31 Tatu L, Jost WH. Anatomy and cervical dystonia: "Dysfunction follows form". J Neural Transm (Vienna) 2017; 124: 237-243
32 Schramm A, Huber D, Möbius C. et al. Involvement of obliquus capitis inferior muscle in dystonic head tremor. Parkinsonism Relat Disord 2017; 44: 119-123
33 Gervasio A, D’Orta G, Mujahed I. et al. Sonographic anatomy of the neck: The suprahyoid region. J Ultrasound 2011; 14: 130-135
34 Gervasio A, Mujahed I, Biasio A. et al. Ultrasound anatomy of the neck: The infrahyoid region. J Ultrasound 2010; 13: 85-89
35 Hong JS, Sathe GG, Niyonkuru C. et al. Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia. Muscle Nerve 2012; 46: 535-539
36 Walter U, Dudesek A, Fietzek UM. A simplified ultrasonography-guided approach for neurotoxin injection into the obliquus capitis inferior muscle in spasmodic torticollis. J Neural Transm (Vienna) 2018; 125: 1037-1042
37 Jabusch HC, Zschucke D, Schmidt A. et al. Focal dystonia in musicians: treatment strategies and long-term outcome in 144 patients. Mov Disord 2005; 20: 1623-1626
38 Furukawa T, Kurihara Y, Masakado Y. The Efficacy of Ultrasound-guided Selective Botulinum Toxin Type A Therapy for Finger Spasticity Following Stroke: A Case Report. Tokai J Exp Clin Med 2019; 44: 20-24
39 Henzel MK, Munin MC, Niyonkuru C. et al. Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections. PM R 2010; 2: 642-646
40 Picelli A, Lobba D, Midiri A. et al. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques. Clin Rehabil 2014; 28: 232-242
41 Santamato A, Micello MF, Panza F. et al. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. J Neurol Sci 2014; 347: 39-43
42 Heinen F, Desloovere K, Schroeder AS. et al. The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol 2010; 14: 45-66
43 Picelli A, Bonetti P, Fontana C. et al. Accuracy of botulinum toxin type A injection into the gastrocnemius muscle of adults with spastic equinus: manual needle placement and electrical stimulation guidance compared using ultrasonography. J Rehabil Med 2012; 44: 450-452
44 Rha DW, Park ES, Jung S. et al. Comparison of ultrasound-guided anterior and posterior approaches for needle insertion into the tibialis posterior in hemiplegic children with spastic cerebral palsy. Am J Phys Med Rehabil 2014; 93: 841-848
45 Rodríguez-Piñero M, Vidal Vargas V, Jiménez Sarmiento AS. Long-Term Efficacy of Ultrasound-Guided Injection of IncobotulinumtoxinA in Piriformis Syndrome. Pain Med 2018; 19: 408-411